(Q47990623)

7 February 2018

title

Thrombospondin-1 inhibits in vitro megakaryocytopoiesis via CD36. (English)

1 reference

7 February 2018

0 references

Mo Yang

1

1 reference

7 February 2018

Karen Li

2

1 reference

7 February 2018

Margaret Heung Ling Ng

3

1 reference

7 February 2018

Patrick Man Pan Yuen

4

1 reference

7 February 2018

Tai Fai Fok

5

1 reference

7 February 2018

Chi Kong Li

6

1 reference

7 February 2018

Philip J Hogg

7

1 reference

7 February 2018

Beng H Chong

8

1 reference

7 February 2018

publication date

1 January 2003

1 reference

7 February 2018

published in

Thrombosis Research

1 reference

7 February 2018

volume

109

1 reference

7 February 2018

issue

1

1 reference

7 February 2018

page(s)

47-54

1 reference

7 February 2018

The functions of thrombospondin-1 and-2.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900142-7

7 January 2021

Thrombospondin, a negative modulator of megakaryocytopoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900142-7

7 January 2021

CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900142-7

7 January 2021

Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900142-7

7 January 2021

Isolation of the thrombospondin membrane receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900142-7

7 January 2021

Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900142-7

7 January 2021

Control of von Willebrand factor multimer size by thrombospondin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900142-7

7 January 2021

Interaction of platelet-derived growth factor with thrombospondin 1

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900142-7

7 January 2021

Expression of interleukin (IL) 1 type I and type II receptors in megakaryocytic cells and enhancing effects of IL-1beta on megakaryocytopoiesis and NF-E2 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900142-7

7 January 2021

Recombinant PDGF enhances megakaryocytopoiesis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900142-7

7 January 2021

Characterization of recombinant soluble human transforming growth factor-β receptor Type II (rhTGF-βsRII)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900142-7

7 January 2021

Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900142-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900142-7

1 reference

7 January 2021

Human platelet alpha granules contain a nonspecific inhibitor of megakaryocyte colony formation: its relationship to type beta transforming growth factor (TGF-beta)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900142-7

7 January 2021

Effects of type beta transforming growth factors on haematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900142-7

7 January 2021

CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900142-7

7 January 2021

Membrane glycoprotein IV (CD36) is physically associated with the Fyn, Lyn, and Yes protein-tyrosine kinases in human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900142-7

7 January 2021

Serotonin stimulates megakaryocytopoiesis via the 5-HT2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900142-7

7 January 2021

10.1016/S0049-3848(03)00142-7

Identifiers

DOI

1 reference

7 February 2018

PubMed ID

12679131

1 reference

7 February 2018